STRM Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

--

Open

--

VWAP

--

Vol

--

Mkt Cap

29.77M

Low

--

Amount

--

EV/EBITDA(TTM)

--

Total Shares

--

EV

35.76M

EV/OCF(TTM)

--

P/S(TTM)

1.18

Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. It sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevID and eValuator. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. In addition, it offers an array of professional services, including system implementation.

Show More

Events Timeline

(ET)

2025-06-16

16:11:56

Streamline Health reports Q1 EPS (40c) vs. (71c) last year

2025-05-29 (ET)

2025-05-29

08:06:23

Streamline Health to acquire MDaudit for $37.4M in cash

2025-05-01 (ET)

2025-05-01

17:18:29

Streamline Health signs new contract for eValuator in Ohio

2025-01-15 (ET)

2025-01-15

06:34:42

Streamline Health announces new eValuator contract with Deaconess Health

2024-12-18 (ET)

2024-12-18

06:35:52

Streamline Health expands presence in Texas with 400-bed health system

2024-11-05 (ET)

2024-11-05

06:40:00

Streamline Health announces eValuator contract with Texas-based health system

2024-10-29 (ET)

2024-10-29

07:42:07

Streamline Health adds Quality Module to third eValuator client

2024-10-23 (ET)

2024-10-23

07:36:58

Streamline Health expands relationship with existing eValuator client

2024-10-08 (ET)

2024-10-08

07:41:10

Streamline Health debuts eValuator quality module

News

Yahoo Finance

2025-12-03Yahoo Finance

Resumption of Trading by Canadian Investment Regulatory Organization - STRM

PRnewswire

2025-07-21PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, TURN, STRM on Behalf of Shareholders

Globenewswire

2025-07-18Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, ENZB, STRM on Behalf of Shareholders

PRnewswire

2025-07-16PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FL, STRM, TXNM, CTLP on Behalf of Shareholders

Globenewswire

2025-07-03Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders

PRnewswire

2025-06-09PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STR, GTLS, STRM, SGN on Behalf of Shareholders

1 Analyst Rating

Wall Street analysts forecast STRM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STRM is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

Current: 0.000

Low

5.00

Averages

5.00

High

5.00

Current: 0.000

Low

5.00

Averages

5.00

High

5.00

Lake Street

NULL

to

Buy

initiated

$8

AI Analysis

2025-12-02

Reason

Lake Street

Price Target

$8

AI Analysis

2025-12-02

initiated

NULL

to

Buy

Reason

Lake Street assumed coverage of Strata Critical Medical with a Buy rating and $8 price target. Strata has staked out "an intriguing position within the organ transplant ecosystem," says the analyst, who contends that recent noise around the potential for increased regulations for the industry "will almost certainly accrue to Strata's benefit."

Valuation Metrics

The current forward P/E ratio for Streamline Health Solutions Inc (STRM.O) is -1.86, compared to its 5-year average forward P/E of -5.86. For a more detailed relative valuation and DCF analysis to assess Streamline Health Solutions Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-5.86

Current PE

-1.86

Overvalued PE

-2.86

Undervalued PE

-8.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-26.78

Current EV/EBITDA

10.81

Overvalued EV/EBITDA

52.42

Undervalued EV/EBITDA

-105.98

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

2.48

Current PS

0.58

Overvalued PS

3.94

Undervalued PS

1.02

Financials

AI Analysis

Annual

Quarterly

Whales Holding STRM

Trading Trends

People Also Watch

Frequently Asked Questions

What is Streamline Health Solutions Inc (STRM) stock price today?

The current price of STRM is 0 USD — it has increased 0 % in the last trading day.

What is Streamline Health Solutions Inc (STRM)'s business?

Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. It sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevID and eValuator. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. In addition, it offers an array of professional services, including system implementation.

What is the price predicton of STRM Stock?

Wall Street analysts forecast STRM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STRM is5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Streamline Health Solutions Inc (STRM)'s revenue for the last quarter?

Streamline Health Solutions Inc revenue for the last quarter amounts to 4.81M USD, increased 11.09 % YoY.

What is Streamline Health Solutions Inc (STRM)'s earnings per share (EPS) for the last quarter?

Streamline Health Solutions Inc. EPS for the last quarter amounts to -0.40 USD, decreased -43.66 % YoY.

How many employees does Streamline Health Solutions Inc (STRM). have?

Streamline Health Solutions Inc (STRM) has 70 emplpoyees as of February 08 2026.

What is Streamline Health Solutions Inc (STRM) market cap?

Today STRM has the market capitalization of 29.77M USD.